Catalyst Pharma

Internal FDA emails reveal how price, Sanders’ pressure played a role in competitor’s approval, Catalyst claims
Internal FDA emails reveal how price, Sanders’ pressure played a role in competitor’s approval, Catalyst claims
Endpoints
Catalyst Pharma
FDA
drug pricing
LEMS
Bernie Sanders
Firdapse
Jacobus Pharmaceuticals
Flag link:
A drug maker courted controversy when it shut out a family-run rival. Now some patients say the medicine isn’t working
A drug maker courted controversy when it shut out a family-run rival. Now some patients say the medicine isn’t working
Stat
Jacobus Pharmaceuticals
compassionate use guidelines
LEMS
Ruzurgi
Firdapse
Catalyst Pharma
Flag link:
Catalyst Pharma Focuses on Firdapse Launch & Label Expansion
Catalyst Pharma Focuses on Firdapse Launch & Label Expansion
Yahoo/Zacks.com
Catalyst Pharma
Firdapse
drug launches
LEMS
Flag link:
With a substantial discount to Catalyst's Firdapse, is Jacobus poised to win physician, payer support for off-label adult LEMS use?
With a substantial discount to Catalyst's Firdapse, is Jacobus poised to win physician, payer support for off-label adult LEMS use?
Endpoints
Jacobus Pharmaceuticals
Catalyst Pharma
Lambert-Eaton myasthenic syndrome
Firdapse
Ruzurgi
Flag link:
Sanders calls on FDA to allow low-cost rivals to $375k Catalyst drug
Sanders calls on FDA to allow low-cost rivals to $375k Catalyst drug
Pharmaforum
drug pricing
Catalyst Pharma
Firdapse
Bernie Sanders
Flag link:
Catalyst defends $375,000 drug price after Bernie Sanders rebuke
Catalyst defends $375,000 drug price after Bernie Sanders rebuke
Reuters
drug pricing
Catalyst Pharma
Bernie Sanders
Flag link:
Firdapse re-catalyzes pricing debate
Firdapse re-catalyzes pricing debate
BioCentury
Firdapse
Catalyst Pharma
Flag link:
Catalyst's Firdapse Receives FDA Approval for Rare Disease
Catalyst's Firdapse Receives FDA Approval for Rare Disease
Yahoo/Zacks.com
Catalyst Pharma
Firdapse
LEMS
FDA
Flag link:
Catalyst shares jazzed by a new round of positive results for a rare neuromuscular disease
Catalyst shares jazzed by a new round of positive results for a rare neuromuscular disease
Endpoints
Catalyst Pharma
Firdapse
Lambert-Eaton myasthenic syndrome
Flag link: